Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Expression of fas/fas ligand (fasL) and its involvement in infiltrating lymphocytes in hepatocellular carcinoma (HCC).

Journal of gastroenterology - 1 Oct 2001

Fukuzawa Y, Takahashi K, Furuta K, Tagaya T, Ishikawa T, Wada K, Omoto Y, Koji T, Kakumu S

Abstract excerpt

BACKGROUND: This study was conducted to examine the expression of Fas/Fas ligand (FasL), to elucidate its relationship with tumor-infiltrating lymphocytes (TILs), and to detect possible gene mutation of Fas/FasL in patients with hepatitis C virus (HCV)-related hepatocellular carcinoma (HCC). METHODS: Indirect immunohistochemical staining was performed on formalin-fixed, paraffin-embedded sections of liver biopsy...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma, Hepatocellular
Share to CD8-Positive T-Lymphocytes

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Fas Ligand Protein

Share to In Situ Nick-End Labeling

Share to Liver Neoplasms

Share to Lymphocyte Subsets

Share to Lymphocytes, Tumor-Infiltrating

Share to Membrane Glycoproteins

Source

Identifiers

PMID: 11686478
DOI: 10.1007/s005350170031

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Expression of fas/fas ligand (fasL) and its involvement in infiltrating lymphocytes in hepatocellular carcinoma (HCC).PMID 11686478Read ↗

Up-regulation of Fas ligand at early stages and down-regulation of Fas at progressed stages of intrahepatic cholangiocarcinoma reflect evasion from immune surveillanceSemantic proximity Read ↗

Expression of Fas and Fas-related molecules in human hepatocellular carcinoma.Semantic proximity Read ↗

Putative association of Fas and FasL gene polymorphisms with clinical outcomes of hepatitis B virus infection.Semantic proximity Read ↗

Fas -670 A/G polymorphism predicts prognosis of hepatocellular carcinoma after curative resection in Chinese Han population.Semantic proximity Read ↗

Significance of Fas antigen-mediated apoptosis in human fulminant hepatic failureSemantic proximity Read ↗

Expression of TNF-related apoptosis-inducing ligand (TRAIL) and its receptors in gastric carcinoma and tumor-infiltrating lymphocytes: a possible mechanism of immune evasion of the tumor.Semantic proximity Read ↗

Evaluation of death pathway genes FAS and FASL polymorphisms in chronic HBV infection.Semantic proximity Read ↗

Fas/Fas ligand gene polymorphism in patients with papillary thyroid cancer in the Turkish population.Semantic proximity Read ↗

Expression of Fas-related genes in human hepatocellular carcinomasSemantic proximity Read ↗

Histological analysis of hepatocellular carcinoma treated by intraarterial combined immunochemotherapy.Semantic proximity Read ↗

Influence of liver hepatitis C virus RNA and hepatitis C virus genotype on FAS-mediated apoptosis after liver transplantation for hepatitis C.Semantic proximity Read ↗

Lack of in vivo blockade of Fas- and TNFR1-mediated hepatocyte apoptosis by the hepatitis C virus.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.